4.2 Article

Current and future antenatal management of isolated congenital diaphragmatic hernia

期刊

SEMINARS IN FETAL & NEONATAL MEDICINE
卷 22, 期 6, 页码 383-390

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.siny.2017.11.002

关键词

Congenital diaphragmatic hernia; Prenatal therapy; Pulmonary hypoplasia; Pulmonary hypertension; Sildenafil

资金

  1. GOSH Children's Charity
  2. Engineering and Physical Sciences Research Council [NS/A000027/1]
  3. Innovative Engineering for Health - Wellcome Trust [WT101957]
  4. UCL/UCLH NIHR Biomedical Research Centre [IS-BRC-1215-20012]
  5. GOSHCC
  6. GOSH NIHR Biomedical Research Centre's funding scheme
  7. Catapult Cell Therapy
  8. Fetal Health Foundation (USA) [ZKD2426, O6510]
  9. Sparks
  10. Erasmus + Programme of the European Commission [2013-0040]
  11. CDHUK
  12. National Institute for Health Research [RP_2014-04-046] Funding Source: researchfish

向作者/读者索取更多资源

Congenital diaphragmatic hernia is surgically correctable, yet the poor lung development determines mortality and morbidity. In isolated cases the outcome may be predicted prenatally by medical imaging. Cases with a poor prognosis could be treated before birth. However, prenatal modulation of lung development remains experimental. Fetoscopic endoluminal tracheal occlusion triggers lung growth and is currently being evaluated in a global clinical trial. Prenatal transplacental sildenafil administration may in due course be a therapeutic approach, reducing the occurrence of persistent pulmonary hypertension, either alone or in combination with fetal surgery. (C) 2017 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据